Stewart Appelrouth, Director at AIM ImmunoTech Inc. (AIM), bought 81,953 shares at $0.19 ($16K) on 2024-11-20, disclosed to the SEC on 2024-11-21.
Open-market purchase of $16k AIM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |
| AIM | BUY | 2023-01-04 | $25K | — | Filing → |
| AIM | BUY | 2021-02-25 | $25K | — | Filing → |
| HEB | BUY | 2019-06-25 | $39K | — | Filing → |